KR101921945B1 - 폐암 바이오마커 및 그것의 용도 - Google Patents

폐암 바이오마커 및 그것의 용도 Download PDF

Info

Publication number
KR101921945B1
KR101921945B1 KR1020147013714A KR20147013714A KR101921945B1 KR 101921945 B1 KR101921945 B1 KR 101921945B1 KR 1020147013714 A KR1020147013714 A KR 1020147013714A KR 20147013714 A KR20147013714 A KR 20147013714A KR 101921945 B1 KR101921945 B1 KR 101921945B1
Authority
KR
South Korea
Prior art keywords
individual
biomarker
lung cancer
biomarkers
delete delete
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020147013714A
Other languages
English (en)
Korean (ko)
Other versions
KR20140082840A (ko
Inventor
마이클 리엘-미한
알렉스 에이. 이. 스튜어트
레이첼 엠. 오스트로프
스테판 얼라릭 윌리암스
에드워드 엔. 브로디
Original Assignee
소마로직, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 소마로직, 인크. filed Critical 소마로직, 인크.
Publication of KR20140082840A publication Critical patent/KR20140082840A/ko
Application granted granted Critical
Publication of KR101921945B1 publication Critical patent/KR101921945B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
KR1020147013714A 2011-10-24 2011-10-24 폐암 바이오마커 및 그것의 용도 Active KR101921945B1 (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/057499 WO2013062515A2 (en) 2011-10-24 2011-10-24 Lung cancer biomarkers and uses thereof

Publications (2)

Publication Number Publication Date
KR20140082840A KR20140082840A (ko) 2014-07-02
KR101921945B1 true KR101921945B1 (ko) 2018-11-26

Family

ID=48168748

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147013714A Active KR101921945B1 (ko) 2011-10-24 2011-10-24 폐암 바이오마커 및 그것의 용도

Country Status (15)

Country Link
EP (1) EP2771692B1 (enExample)
JP (1) JP5986638B2 (enExample)
KR (1) KR101921945B1 (enExample)
CN (2) CN103890586B (enExample)
AU (1) AU2011378427B8 (enExample)
BR (1) BR112014006432B8 (enExample)
CA (3) CA2847188C (enExample)
ES (1) ES2674318T3 (enExample)
IL (2) IL231426A (enExample)
IN (1) IN2014CN01787A (enExample)
MX (1) MX355416B (enExample)
NZ (1) NZ621733A (enExample)
SG (1) SG11201400375SA (enExample)
WO (1) WO2013062515A2 (enExample)
ZA (1) ZA201401476B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX355020B (es) 2010-07-09 2018-04-02 Somalogic Inc Biomarcadores de cancer de pulmon y usos de los mismos.
WO2014179959A1 (en) * 2013-05-09 2014-11-13 The Procter & Gamble Company Method and system for assessing health condition
ES3014093T3 (en) 2014-07-30 2025-04-16 Harvard College Method for determining nucleic acids
CN104263723B (zh) * 2014-09-15 2017-06-06 南京医科大学 一种与原发性肺癌辅助诊断相关的低频高外显性遗传标志物及其应用
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
KR102087373B1 (ko) * 2015-09-11 2020-03-10 주식회사 압타머사이언스 비소세포성 폐암 진단용 단백질 바이오마커 패널 및 이를 이용한 비소세포성 폐암 진단 방법
KR102086935B1 (ko) * 2015-11-05 2020-03-09 비지아이 션전 폐 선암종을 검출하기 위한 생체마커 및 그의 사용
AU2017235661B2 (en) * 2016-03-18 2023-06-08 Caris Science, Inc. Oligonucleotide probes and uses thereof
KR101853118B1 (ko) * 2016-09-02 2018-04-30 주식회사 바이오인프라생명과학 피험체의 폐암 진단을 위한 복합 바이오마커군, 이를 이용하는 폐암 진단용 키트, 복합 바이오마커군의 정보를 이용하는 방법 및 이를 수행하는 컴퓨팅 시스템
EP4386761A3 (en) * 2016-11-08 2024-09-04 President and Fellows of Harvard College Matrix imprinting and clearing
JP7128196B2 (ja) * 2017-03-01 2022-08-30 エフ．ホフマン－ラ ロシュ アーゲー 検体の存在に関する生体サンプルの分類のためのシステムおよび方法
US11788123B2 (en) 2017-05-26 2023-10-17 President And Fellows Of Harvard College Systems and methods for high-throughput image-based screening
CN109116023B (zh) * 2018-06-14 2021-06-04 郑州大学第一附属医院 一种肺癌标志物抗-mmp12自身抗体及其应用
CN109470859A (zh) * 2018-11-04 2019-03-15 华东医院 一种外泌体蛋白作为鉴别肺结节良恶性标志物及其应用
CN113366116A (zh) 2018-12-13 2021-09-07 哈佛学院院长及董事 用于merfish和其他应用的扩增方法和系统
EP3671210A1 (en) * 2018-12-21 2020-06-24 Biosystems International KFT Lung cancer protein epitomic biomarkers
WO2020167471A1 (en) * 2019-02-15 2020-08-20 Biodesix, Inc. Predictive test for identification of early stage nsclc patients at high risk of recurrence after surgery
CN110473167B (zh) * 2019-07-09 2022-06-17 哈尔滨工程大学 一种基于深度学习的尿沉渣图像识别系统及方法
CN112892619B (zh) * 2019-12-04 2022-07-15 香港城市大学深圳研究院 弧形边缘截面的pdms母模、微流控阀和芯片及其制备
WO2022103843A1 (en) * 2020-11-11 2022-05-19 George Mason Research Foundation, Inc. Laser capture microdissection visualization chemistry
KR102613772B1 (ko) * 2021-02-02 2023-12-14 제노마인(주) 폐암 혈액 바이오마커의 검출 방법 및 키트
WO2025144995A1 (en) * 2023-12-29 2025-07-03 Novelna Inc. Lung cancer detection proteins and methods of use thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030215895A1 (en) * 2000-08-18 2003-11-20 Wennerberg Anne Elizabeth Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
US20080305962A1 (en) 2005-07-29 2008-12-11 Ralph Markus Wirtz Methods and Kits for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapies
US20090023149A1 (en) 2005-12-01 2009-01-22 Steen Knudsen Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
US20100070191A1 (en) * 2008-09-09 2010-03-18 Somalogic, Inc. Lung Cancer Biomarkers and Uses Thereof
US20100131432A1 (en) 2008-11-17 2010-05-27 Kennedy Giulia C Methods and compositions of molecular profiling for disease diagnostics
WO2011109440A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings Biomarkers for theranostics
US20110236903A1 (en) 2008-12-04 2011-09-29 Mcclelland Michael Materials and methods for determining diagnosis and prognosis of prostate cancer
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335170B1 (en) * 1999-02-22 2002-01-01 Torben F. Orntoft Gene expression in bladder tumors
EP1787122B1 (en) * 2004-08-10 2010-10-06 Oncotherapy Science, Inc. NON-SMALL CELL LUNG CANCER-RELATED GENE, ANLN, AND ITS INTERACTIONS WITH RhoA
WO2007013665A2 (en) * 2005-07-27 2007-02-01 Oncotherapy Science, Inc. Method of diagnosing small cell lung cancer
US8014957B2 (en) * 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
EP2090665A2 (en) * 2006-10-20 2009-08-19 Exiqon A/S Novel human microRNAs associated with cancer
GB0803192D0 (en) * 2008-02-22 2008-04-02 Mubio Products Bv SCLC biomarker panel
CA3011730C (en) * 2008-09-09 2022-05-17 Somalogic, Inc. Lung cancer biomarkers and uses thereof
WO2011100472A1 (en) * 2010-02-10 2011-08-18 The Regents Of The University Of California Salivary transcriptomic and proteomic biomarkers for breast cancer detection

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030215895A1 (en) * 2000-08-18 2003-11-20 Wennerberg Anne Elizabeth Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
US20080305962A1 (en) 2005-07-29 2008-12-11 Ralph Markus Wirtz Methods and Kits for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapies
US20090023149A1 (en) 2005-12-01 2009-01-22 Steen Knudsen Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
US20100070191A1 (en) * 2008-09-09 2010-03-18 Somalogic, Inc. Lung Cancer Biomarkers and Uses Thereof
US20100131432A1 (en) 2008-11-17 2010-05-27 Kennedy Giulia C Methods and compositions of molecular profiling for disease diagnostics
US20110236903A1 (en) 2008-12-04 2011-09-29 Mcclelland Michael Materials and methods for determining diagnosis and prognosis of prostate cancer
WO2011109440A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings Biomarkers for theranostics
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Kearse K P et al, International Journal of Cancer (2000), vol. 88, no. 88, pp. 866-872.

Also Published As

Publication number Publication date
IL231426A0 (en) 2014-04-30
CA3064363C (en) 2022-05-17
SG11201400375SA (en) 2014-04-28
JP2015501154A (ja) 2015-01-15
IN2014CN01787A (enExample) 2015-05-29
BR112014006432B8 (pt) 2022-10-25
CA3006793C (en) 2020-02-18
MX355416B (es) 2018-04-18
CN103890586B (zh) 2016-06-29
BR112014006432B1 (pt) 2021-04-06
AU2011378427A8 (en) 2015-08-27
CA3006793A1 (en) 2013-05-02
MX2014004860A (es) 2014-05-27
AU2011378427B2 (en) 2015-07-16
CN106168624B (zh) 2018-03-13
WO2013062515A3 (en) 2014-04-17
EP2771692A4 (en) 2015-08-26
ZA201401476B (en) 2016-06-29
CN103890586A (zh) 2014-06-25
KR20140082840A (ko) 2014-07-02
IL231426A (en) 2017-06-29
CA3064363A1 (en) 2013-05-02
CA2847188A1 (en) 2013-05-02
ES2674318T3 (es) 2018-06-28
JP5986638B2 (ja) 2016-09-06
CN106168624A (zh) 2016-11-30
EP2771692A2 (en) 2014-09-03
WO2013062515A2 (en) 2013-05-02
IL252163A0 (en) 2017-07-31
AU2011378427B8 (en) 2015-08-27
CA2847188C (en) 2020-02-18
AU2011378427A1 (en) 2013-05-16
EP2771692B1 (en) 2018-04-18
NZ621733A (en) 2015-05-29
BR112014006432A2 (pt) 2017-04-04

Similar Documents

Publication Publication Date Title
KR101921945B1 (ko) 폐암 바이오마커 및 그것의 용도
KR101658347B1 (ko) 폐암 바이오마커 및 그것들의 용도
KR101857462B1 (ko) 췌장암 바이오마커 및 그것의 용도
KR101870123B1 (ko) 폐암 바이오마커 및 그것의 용도
US20120143805A1 (en) Cancer Biomarkers and Uses Thereof
WO2011031344A1 (en) Cancer biomarkers and uses thereof
US20220065872A1 (en) Lung Cancer Biomarkers and Uses Thereof
HK1229002B (en) Lung cancer biomarkers and uses thereof
HK1229002A (en) Lung cancer biomarkers and uses thereof
HK1229002A1 (en) Lung cancer biomarkers and uses thereof
HK1229003A1 (en) Pancreatic cancer biomarkers and uses thereof
HK1229003B (zh) 胰腺癌生物标记及其用途
HK1196429A (en) Lung cancer biomarkers and uses thereof
HK1196429B (en) Lung cancer biomarkers and uses thereof

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8